1.11.2012 Official Journal of the European Union L 305/27 COMMISSION IMPLEMENTING DECISION of 30 October 2012 allowing Member States to extend provisional authorisations granted for the new active substances ametoctradin (initially applied for under the development code BAS 650 F) and disodium phosphonate (notified under document C(2012) 7581) (Text with EEA relevance) (2012/677/EU) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market ('), and in particular the fourth subparagraph of Article 8(1) thereof, Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414[EEC (3, and in particular Article 80(1)(a) thereof, Whereas: 1 ( ( ( ( 1 2 3 4 In accordance with Article 80(1)(a) of Regulation (EC) No 1107/2009, Directive 91/414/EEC shall continue to apply to active substances for which a decision has been adopted in accordance with Article 6(3) of Directive 91/414/EEC before 14 June 2011. In accordance with Article 6(2) of Directive 91/414/EEC, in September 2008 the Netherlands received an appli- cation from BASF SE for the inclusion of the active substance ametoctradin (initially applied for under the development code BAS 650 F) in Annex I to Directive 91/414[/EEC. Commission Decision 2009/535/EC () confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex Il and Annex III to that Directive. In accordance with Article 6(2) of Directive 91/414/EEC, in May 2008 France received an application from ISK Biosciences Europe SA for the inclusion of the active substance disodium phosphonate in Annex [ to Directive 91/414/[EEC. Commission Decision 2008/953EC (*) confirmed that the dossier was complete and could be considered as satisfying, in prin- ciple, the data and information requirements of Annex II and Annex III to that Directive. 230, 19.8.1991, p. 1. 309, 24.11.2009, p. 1. ) O] L ) O] L ) O] L 179, 10.7.2009, p. 66. ) OJ L 338, 17.12.2008, p. 62. ) (6) Confirmation of the completeness of the dossiers was necessary in order to allow them to be examined in detail and to allow Member States the possibility of granting provisional authorisations, for periods of up to three years, for plant protection products containing the active substances concerned, while complying with the conditions laid down in Article 8(1) of Directive 91/414[EEC and, in particular, the conditions relating to the detailed assessment of the active substances and the plant protection products in the light of the requirements laid down by that Directive. For these active substances, the effects on human health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/EEC, for the uses proposed by the applicants. The rapporteur Member States submitted the draft assessment reports to the Commission on 15 September 2009 (ame- toctradin) and on 27 August 2009 (disodium phos- phonate), respectively. Following submission of the draft assessment reports by the rapporteur Member States, it has been found to be necessary to request further information from the applicants and to have the rapporteur Member States examine that information and submit their assessment. Therefore, the examination of the dossiers is still ongoing and it will not be possible to complete the evaluation within the timeframe provided for in Directive 91/414/EEC. As the evaluation so far has not identified any reason for immediate concern, Member States should be given the possibility of prolonging provisional authorisations granted for plant protection products containing the active substances concerned for a period of 24 months in accordance with the provisions of Article 8 of Directive 91/414/EEC so as to enable the examination of the dossiers to continue. It is expected that the evaluation and decision-making process with respect to a decision on a possible approval in accordance with Article 13(2) of Regulation (EC) No 1107/2009 for ametoctradin and disodium phosphonate will have been completed within 24 months. The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,